Close
Show

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

United States-Switzerland Strike A Drug Inspection Accord


The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good...

5 FDA Announcements To Pay Attention To In The 2023 Q1


The biotechnology sector had a decline in 2022 that went beyond just falling stock prices....

Watch Out For These Potential Best-Seller Drugs In 2023


In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential...

Study Reveals That Gut Microbiome Is Crucial In Parkinsons


Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with...

The AMR Action Fund Invests in BioVersys in Fight Against Drug-Resistant Bacteria


The AMR Action Fund, a public-private partnership investing in biotech companies developing antimicrobials, has invested...

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets


AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company that utilizes its human memory B cell...
Sanofi invests to make France its world class center of excellence in vaccine research and production

BMS, Dragonfly Enter Exclusive License for Sixth TriNKET Immunotherapy Candidate


Bristol Myers Squibb has exercised its option under a research collaboration with Dragonfly Therapeutics, Inc,...

FUJIFILM Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies


FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem...
Aurisco to Build Oligonucleotides Manufacturing Facility in China

Aurisco to Build Oligonucleotides Manufacturing Facility in China


Aurisco, a pharmaceutical company and contract development and manufacturing organization (CDMO) in China, is cooperating...
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics


Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and CytomX Therapeutics,...